Randomized phase 2 three-arm trial of lenvatinib (LEN), everolimus (EVE), and LEN plus EVE in patients (pts) with metastatic renal cell carcinoma (mRCC) Meeting Abstract
| Authors: | Motzer, R.; Hutson, T.; Glen, H.; Michaelson, M. D.; Molina, A.; Eisen, T.; Jassem, J.; Zolnierek, J.; Maroto, P.; Mellado, B.; Melichar, B.; Tomasek, J.; Kim, H. J.; Wood, K.; Dutcus, C.; Larkin, J. |
| Abstract Title: | Randomized phase 2 three-arm trial of lenvatinib (LEN), everolimus (EVE), and LEN plus EVE in patients (pts) with metastatic renal cell carcinoma (mRCC) |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 38 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2015 Oct 9-13 |
| Meeting Location: | Basel, Switzerland |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2015-10-01 |
| Start Page: | 203 |
| End Page: | 204 |
| Language: | English |
| ACCESSION: | WOS:000364268800489 |
| PROVIDER: | wos |
| PUBMED: | 26461956 |
| DOI: | 10.1159/000439070 |
| Notes: | Meeting Abstract: V673 -- [Annual Meeting of the German, Austrian and Swiss Societies for Haematology and Medical Oncology] -- Source: Wos |
